Newcells Biotech Overview

  • Founded
  • 2014
Founded
  • Status
  • Private
  • Employees
  • 27
Employees
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $7.24M
Latest Deal Amount
  • Investors
  • 3

Newcells Biotech General Information

Description

Developer of a biotechnology platform designed to produce induced pluripotent stem cells. The company's platform is at the forefront of the production and differentiation of human-induced pluripotent stem cells (hiPSC), which is quickly advancing the field of pre-clinical disease modeling and drug safety evaluation, enabling researchers to research and test new drugs and screen potential drug molecules for efficacy and toxicity.

Contact Information

Website
www.newcellsbiotech.co.uk
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Biotechnology
Primary Office
  • The Biosphere Drayman's Way
  • Newcastle Helix
  • Newcastle Upon Tyne NE4 5BX
  • England, United Kingdom
+44 0191 000 0000

Newcells Biotech Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Newcells Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 23-Feb-2021 $7.24M 000.00 000.00 Completed Generating Revenue
4. Early Stage VC 000 00.00 Completed Generating Revenue
3. Early Stage VC 04-Jul-2018 00.000 00.000 00.000 Completed Generating Revenue
2. Grant 10-Oct-2016 $239K Completed Generating Revenue
1. Seed Round 02-Sep-2015 $239K $239K 00.000 Completed Generating Revenue
To view Newcells Biotech’s complete valuation and funding history, request access »

Newcells Biotech Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
F2 Ordinary 000,000 00.000000 00.00 00.00 00 00.00 0.000
F1 Ordinary 000,000 00.000000 00.00 00.00 00 00.00 00.000
E Ordinary 000,000 00.000000 00.00 00.00 00 00.00 00.000
F2 Ordinary 00,000 00.000000 00.00 00.00 00 00.00 0.00
F1 Ordinary 000,000 00.000000 00.00 00.00 00 00.00 0.000
E Ordinary 00,000 00.000000 00.00 00.00 00 00.00 0.000
D2 Ordinary 000,000 00.000000 00.00 00.00 00 00.00 0.000
D1 Ordinary 000,000 00.000000 00.00 00.00 00 00.00 00.000
C Ordinary 337,969 $0.000138 $2.04 $2.04 1x $2.04 6.67%
Ordinary A 29,500 $0.000138 $7.18 $7.18 1x $7.18 0.58%
To view Newcells Biotech’s complete cap table history, request access »

Newcells Biotech Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a biotechnology platform designed to produce induced pluripotent stem cells. The company's platform is at t
Drug Discovery
Newcastle Upon Tyne, United Kingdom
27 As of 2021
000.00
00.00 0000-00-00
0000000000 0 000.00

00000000

magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex
0000 000000000
Cambridge, United Kingdom
00 As of 0000
000.00
00.00 0000-00-00
0000000000 0 000.00

000 0000

ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et do
0000 000000000
Seattle, WA
00 As of 0000
000.00
0000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Newcells Biotech Competitors (24)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
DefiniGEN Venture Capital-Backed Cambridge, United Kingdom 00 000.00 0000000000 0 000.00
000 0000000000000 Venture Capital-Backed Seattle, WA 00 000.00 0000000000 000.00
0000000 0000000000 Venture Capital-Backed South San Francisco, CA 00 000.00 00000000000 000.00
0000 00000000000 Private Equity-Backed Cambridgeshire, United Kingdom 00 00.000 0000000 0000 00.000
00000000 Venture Capital-Backed South San Francisco, CA 00 00000 0000000000 00000
You’re viewing 5 of 24 competitors. Get the full list »

Newcells Biotech Executive Team (3)

Name Title Board Seat Contact Info
Michael Nicholds Chief Executive Officer & Board Member
Lyle Armstrong Ph.D Chief Scientific Officer & Board Member
Majlinda Lako Ph.D Founder
To view Newcells Biotech’s complete executive team members history, request access »

Newcells Biotech Board Members (5)

Name Representing Role Since
Frank Armstrong MD Self Board Member 000 0000
Lyle Armstrong Ph.D Newcells Biotech Chief Scientific Officer & Board Member 000 0000
Michael Nicholds Newcells Biotech Chief Executive Officer & Board Member 000 0000
Sandy Primrose Self Chairman 000 0000
Timothy Levett NVM Private Equity Board Member 000 0000
To view Newcells Biotech’s complete board members history, request access »

Newcells Biotech Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Newcells Biotech Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Mercia Asset Management Venture Capital Minority 000 0000 000000 0
NVM Private Equity PE/Buyout Minority 000 0000 000000 0
Northstar Ventures Venture Capital Minority 000 0000 000000 0
To view Newcells Biotech’s complete investors history, request access »

Ready to get started?

Request a free trial